Inmunología, Oftalmología y ORL
Departamento
![Foto de Inmunología, Oftalmología y ORL](/img/uploaded/7383705E4165CCC3E1D5745D79764C47.png)
![Foto de Instituto de Oftalmología Aplicada de Valladolid](/img/noimage_org.png)
Instituto de Oftalmología Aplicada de Valladolid
Valladolid, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Oftalmología Aplicada de Valladolid (6)
2022
-
Efficacy, safety and cost-effectiveness of methotrexate, adalimumab or their combination in non-infectious non-anterior uveitis: a protocol for a multicentre, randomised, parallel three arms, active-controlled, phase III open label with blinded outcome assessment study
BMJ open, Vol. 12, Núm. 3, pp. e051378
2021
-
Recommendations for ophthalmologic practice during the easing of COVID-19 control measures
Acta Ophthalmologica, Vol. 99, Núm. 7, pp. e973-e983
2019
-
Transforming growth factor beta-induced p.(L558P) variant is associated with autosomal dominant lattice corneal dystrophy type IV in a large cohort of Spanish patients
Clinical and Experimental Ophthalmology, Vol. 47, Núm. 7, pp. 871-880
2018
-
Controlled Adverse Environment Chambers in Dry Eye Research
Current Eye Research, Vol. 43, Núm. 4, pp. 445-450
2015
-
Association between SNPs of metalloproteinases and prostaglandin f2α receptor genes and latanoprost response in open-angle glaucoma
Ophthalmology, Vol. 122, Núm. 5, pp. 1040-1048.e4
2011
-
Activation of MAPK signaling pathway and NF-κB activation in pterygium and ipsilateral pterygium-free conjunctival specimens
Investigative Ophthalmology and Visual Science, Vol. 52, Núm. 8, pp. 5842-5852